68071 3375 1
Spironolactone Tablet, Film Coated
Product Images NDC 68071-3375
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)
Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)
This appears to be a table showing various measurements for a study or trial. It includes data on demographics (such as sex and race), medical history (such as diabetes), medications taken (such as Spironolactone), and some measurements (such as Liver and Kt). Without additional context or clearer formatting, it is difficult to determine the exact purpose or interpretation of the data.*
Chemical Structure (Spironolactone Structure Image)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
